Overview

Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.

Status:
Completed

Trial end date:
2007-10-01

Target enrollment:

Participant gender:

Summary

A Multicenter, Double-blind 16 Week Study on the augmentation of atypical antipsychotic with Aripiprazole in patients with Schizophrenia with inadequate response to antipsychotic treatment.

Phase:

Phase 4

Details

Lead Sponsor:

Otsuka Pharmaceutical Development & Commercialization, Inc.

Collaborator:

Otsuka America Pharmaceutical

Treatments:

Aripiprazole
Quetiapine Fumarate
Risperidone